title: Reply: early intravenous beta-blockade before primary percutaneous coronary intervention gives major benefits apparently without side effects.
authors.forename: Borja
authors.initials: B
authors.lastname: Ibanez
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use*; D061345:Early Medical Intervention; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D008790:Metoprolol